Morpholine-3-carboxylic acid hydrochloride → HCID 90043507, compound

HRID 524774Notes

Reaction equation

HRID 524774 reaction equation
Br[CH2:2][C:3]1[NH:8][C:7]([C:9]2[S:10][C:11]([F:14])=[CH:12][N:13]=2)=[N:6][CH:5]([C:15]2[CH:20]=[CH:19][C:18]([Cl:21])=[CH:17][C:16]=2[Cl:22])[C:4]=1[C:23]([O:25][CH2:26][CH3:27])=[O:24].Cl.[NH:29]1[CH2:34][CH2:33][O:32][CH2:31][CH:30]1[C:35]([OH:37])=[O:36]>>[Cl:22][C:16]1[CH:17]=[C:18]([Cl:21])[CH:19]=[CH:20][C:15]=1[CH:5]1[N:6]=[C:7]([C:9]2[S:10][C:11]([F:14])=[CH:12][N:13]=2)[NH:8][C:3]([CH2:2][N:29]2[CH2:34][CH2:33][O:32][CH2:31][CH:30]2[C:35]([OH:37])=[O:36])=[C:4]1[C:23]([O:25][CH2:26][CH3:27])=[O:24]

Participants

3

Procedure

Ethyl 6-(bromomethyl)-4-(2,4-dichlorophenyl)-2-(5-fluorothiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate (0.52 g, 1.06 mmol) was reacted with morpholine-3-carboxylic acid hydrochloride (0.21 g, 1.28 mmol) according to the procedure as described in Example 1, Step C to give the title compound as a yellowish solid (0.35 g, 60%). The compound was characterized by the following spectroscopic data:

Sources & evidence

ORD record
ord-49e17f9a734e416db27cf7b5067120e3
Source dataset
uspto-grants-2016_05
Patent number
US09340538B2

Reaction notes

Loading…